Pharmacy Executives: Leadership Issues and Associated Skills, Knowledge, and Abilities in the U.S. Department of Defense

Leadership for Health System Transformation: What's Needed in Canada? Brief for the Canadian Nurses Association's National Expert Commission on The Health of Our Nation – The Future of Our Health System

“…Recommendation 2: Develop avant-garde executive leadership competencies A review and synthesis of recent literature on professional competence (Arnold et al 2006;Englebright and Perlin 2008;Hartman and Crow 2002;Huston 2008;Kirk 2008Kirk , 2009May and Ferguson-Paré 1997;Meadows et al 2003Meadows et al , 2005Misener et al 1997;Palarca et al 2008;Porter-O'Grady and Malloch 2009;Sentell and Fenstuen 1998;Stefl 2008;Sutto et al 2008) revealed high consistency with the Canadian College of Health Service Executives' competencies (2005), which include leadership, communication, lifelong learning, consumer and community responsiveness and public relations, political awareness in the health environ-ment, conceptual skills, results-oriented management, resources management and compliance with standards, ethics and laws (see Appendix A).…”

Development of consensus guidance to facilitate service redesign around pharmacist prescribing in UK hospital practice

“…These relate to: synthesis of criteria to assess the quality of documentation associated with the Medicines Utilisation Review in England [19]; to agree the definition of 'dispensing error' within community pharmacy [20]; to develop competencies associated with training needs in public health for Scottish community pharmacists [21]; and to generate a model of pharmaceutical care for the patient with type 2 diabetes mellitus in primary care [22]. In the USA, consensus studies have assisted the development of: components required for training of community pharmacists [23]; agreeing present and future challenges facing pharmacy executive [24,25]; and formulating a list of clinically significant drug-drug interactions between oral anticancer drugs and concomitant therapies [26].…”